Brentuximab vedotin in relapsed/refractory Hodgkin’s lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

類似資料

• First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi
  著者:: Broccoli, A., 等
  出版事項: (2019)
• Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients
  著者:: Zinzani, Pier Luigi, 等
  出版事項: (2015)
• Brentuximab vedotin followed by ABVD +/− radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study
  著者:: Federico, Massimo, 等
  出版事項: (2016)
• Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients
  著者:: Gandolfi, Letizia, 等
  出版事項: (2016)
• Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase II study of FIL ONLUS
  著者:: Stefoni, Vittorio, 等
  出版事項: (2020)